By proceeding, you agree to our Terms of Use and Privacy Policy.
Ceo & President
#immunomodulating
#NorthAmerica
Thomas Tillett – Cofounder and CEO of MBF Therapeutics, a life science company, is developing innovative gene-based check point inhibitor and immunomodulating immunotherapies to treat cancer and infec